Actinium Pharmaceuticals
ATNM
#10611
Rank
โ‚ฌ21.63 M
Marketcap
0,69ย โ‚ฌ
Share price
1.32%
Change (1 day)
-48.52%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2026 (TTM): -โ‚ฌ21.78 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ0.09 Million. In 2025 the company made an earning of -โ‚ฌ31.36 Million, an increase over its 2024 earnings that were of -โ‚ฌ36.44 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ21.78 Million-30.54%
2025 -โ‚ฌ31.36 Million-13.95%
2024 -โ‚ฌ36.44 Million-18.87%
2023 -โ‚ฌ44.91 Million52.24%
2022 -โ‚ฌ29.5 Million36.61%
2021 -โ‚ฌ21.6 Million11.48%
2020 -โ‚ฌ19.37 Million1.46%
2019 -โ‚ฌ19.09 Million-7.37%
2018 -โ‚ฌ20.61 Million-11.46%
2017 -โ‚ฌ23.28 Million10.67%
2016 -โ‚ฌ21.04 Million15.7%
2015 -โ‚ฌ18.18 Million-14.86%
2014 -โ‚ฌ21.36 Million129.19%
2013 -โ‚ฌ9.32 Million-8.55%
2012 -โ‚ฌ10.19 Million
2010 โ‚ฌ0 M-152.15%
2009 -โ‚ฌ0.02 Million-39.8%
2008 -โ‚ฌ0.03 Million120.29%
2007 -โ‚ฌ0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Genocea Biosciences
GNCA
-โ‚ฌ32.17 Million 45.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚ฌ0.16 M-100.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ0.33 B-1,611.42%๐Ÿ‡บ๐Ÿ‡ธ USA